Zobrazeno 1 - 3
of 3
pro vyhledávání: '"April K Sikaffy"'
Autor:
Jack N Hutter, Jason C. Sousa, Elizabeth H. Duncan, Kristin Mills, Daniel J. Selig, Donna Tosh, Paige E. Waterman, Jesse P. DeLuca, Lucas Poon, Patrick S. Twomey, Susan Cicatelli, Jason W. Bennett, Melinda Hamer, Meshell Morrison, Christine Lee, James E. Moon, Jeffrey R. Livezey, Martha Sedegah, Thomas Oliver, April K Sikaffy, Mara Kreishman-Deitrick, Chau Vuong
Publikováno v:
Malaria Journal, Vol 19, Iss 1, Pp 1-14 (2020)
Malaria Journal
Malaria Journal
Background Malaria remains the top infectious disease threat facing the U.S. military in many forward operating environments. Compliance with malaria chemoprophylaxis remains a critical component in preventing malaria in the deployed Service Member.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc25e2beae32e9e6231ff28ffb07bfb4
http://link.springer.com/article/10.1186/s12936-020-03409-z
http://link.springer.com/article/10.1186/s12936-020-03409-z
Autor:
James E, Moon, Christian, Ockenhouse, Jason A, Regules, Johan, Vekemans, Cynthia, Lee, Ilin, Chuang, Magali, Traskine, Erik, Jongert, Karen, Ivinson, Danielle, Morelle, Jack L, Komisar, Marc, Lievens, Martha, Sedegah, Lindsey S, Garver, April K, Sikaffy, Norman C, Waters, William Ripley, Ballou, Opokua, Ofori-Anyinam, Linda, Murray
Publikováno v:
The Journal of Infectious Diseases
Background A previous RTS,S/AS01B vaccine challenge trial demonstrated that a 3-dose (0-1-7–month) regimen with a fractional third dose can produce high vaccine efficacy (VE) in adults challenged 3 weeks after vaccination. This study explored the V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8469f62f402d7500db38f274e675fb01
https://doi.org/10.1093/infdis/jiaa421
https://doi.org/10.1093/infdis/jiaa421
Autor:
James E, Moon, Melissa E, Greenleaf, Jason A, Regules, Muriel, Debois, Elizabeth H, Duncan, Martha, Sedegah, Ilin, Chuang, Cynthia K, Lee, April K, Sikaffy, Lindsey S, Garver, Karen, Ivinson, Evelina, Angov, Danielle, Morelle, Marc, Lievens, Christian F, Ockenhouse, Viseth, Ngauy, Opokua, Ofori-Anyinam
Publikováno v:
Vaccine. 39(43)
We previously demonstrated that RTS,S/AS0149 participants (P-Fx: 25; NP-Fx: 24) received a fractional (1/5th dose-volume) RTS,S/AS01Overall vaccine efficacy against re-challenge was 53% (95% CI: 37-65%), and similar for P-Fx (52% [95% CI: 28-68%]) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::08a1214d8923673f1b6898ad646b9bc8
https://pubmed.ncbi.nlm.nih.gov/34593270
https://pubmed.ncbi.nlm.nih.gov/34593270